share_log

NexImmune | DEFA14A: Others

NexImmune | DEFA14A:其他

SEC announcement ·  01/18 13:00
牛牛AI助理已提取核心訊息
NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders originally scheduled for January 18, 2024, to a new date of February 7, 2024. The meeting, which will be held virtually via live webcast, is set to discuss the approval of the company's liquidation and dissolution as well as the Plan of Liquidation and Dissolution. Stockholders as of the record date, November 6, 2023, are entitled to vote at the rescheduled meeting. The company has provided various methods for stockholders to submit their proxy votes, including over the Internet, by telephone, by mail, or directly at the Special Meeting. Voting will remain open until 11:59 p.m. Eastern Time on February 6, 2024, for Internet and telephone submissions, while mailed proxies must be received by the same date. NexImmune has engaged Laurel Hill Advisory Group, LLC as its proxy solicitor to assist stockholders with the voting process and any related inquiries.
NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders originally scheduled for January 18, 2024, to a new date of February 7, 2024. The meeting, which will be held virtually via live webcast, is set to discuss the approval of the company's liquidation and dissolution as well as the Plan of Liquidation and Dissolution. Stockholders as of the record date, November 6, 2023, are entitled to vote at the rescheduled meeting. The company has provided various methods for stockholders to submit their proxy votes, including over the Internet, by telephone, by mail, or directly at the Special Meeting. Voting will remain open until 11:59 p.m. Eastern Time on February 6, 2024, for Internet and telephone submissions, while mailed proxies must be received by the same date. NexImmune has engaged Laurel Hill Advisory Group, LLC as its proxy solicitor to assist stockholders with the voting process and any related inquiries.
NexImmune, Inc.宣佈將原定於2024年1月18日舉行的股東特別會議延期至2024年2月7日的新日期。該會議將通過網絡直播虛擬舉行,旨在討論公司清算和解散以及清算和解散計劃的批准。截至創紀錄的日期,即2023年11月6日,股東有權在重新安排的會議上投票。該公司爲股東提供了多種提交代理投票的方法,包括通過互聯網、電話、郵寄或直接在特別會議上提交。互聯網和電話提交的投票將持續到美國東部時間2024年2月6日晚上 11:59,而郵寄的代理必須在同一日期之前收到。NexImmune已聘請勞雷爾·希爾諮詢集團有限責任公司作爲其代理律師,以協助股東進行投票程序和任何相關查詢。
NexImmune, Inc.宣佈將原定於2024年1月18日舉行的股東特別會議延期至2024年2月7日的新日期。該會議將通過網絡直播虛擬舉行,旨在討論公司清算和解散以及清算和解散計劃的批准。截至創紀錄的日期,即2023年11月6日,股東有權在重新安排的會議上投票。該公司爲股東提供了多種提交代理投票的方法,包括通過互聯網、電話、郵寄或直接在特別會議上提交。互聯網和電話提交的投票將持續到美國東部時間2024年2月6日晚上 11:59,而郵寄的代理必須在同一日期之前收到。NexImmune已聘請勞雷爾·希爾諮詢集團有限責任公司作爲其代理律師,以協助股東進行投票程序和任何相關查詢。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。